Mack MJ, et al. Transcatheter aortic-valve replacement with a balloon-expandable valve in low-risk patients. N Engl J Med 2019; 380:1695–1705.
Adams DH, et al. Transcatheter aortic-valve replacement with a self-expanding prosthesis. N Engl J Med 2014; 370:1790–1798.
Najjar M, et al. Acute kidney injury after aortic valve replacement: incidence, risk factors and outcomes. Expert Rev Cardiovasc Ther 2015; 13:301–316.
Elhmidi Y, et al. Acute kidney injury after transcatheter aortic valve implantation: Incidence, predictors and impact on mortality. Arch Cardiovasc Dis 2014; 107:133–139.
Stortecky S, et al. Transcatheter aortic valve implantation or surgical aortic valve replacement as redo procedure after prior coronary artery bypass grafting. Ann Thorac Surg 2011; 92:1324–1330.
Thongprayoon C, et al. Incidence and risk factors of acute kidney injury following transcatheter aortic valve replacement. Nephrology (Carlton) 2016; 21:1041–1046.
Barbash IM, et al. Incidence and predictors of acute kidney injury after transcatheter aortic valve replacement. Am Heart J 2012; 163:1031–1036.
Bagur R, et al. Acute kidney injury following transcatheter aortic valve implantation: Predictive factors, prognostic value, and comparison with surgical aortic valve replacement. Eur Heart J 2010; 31:865–874.
Elhmidi Y, et al. Incidence and predictors of acute kidney injury in patients undergoing transcatheter aortic valve implantation. Am Heart J 2011; 161:735–739.
Khawaja MZ, et al. The effects of VARC-defined acute kidney injury after transcatheter aortic valve implantation (TAVI) using the Edwards bioprosthesis. EuroIntervention 2012; 8:563–570.
Thongprayoon C, et al. AKI after transcatheter or surgical aortic valve replacement. J Am Soc Nephrol 2016; 27:1854–1860.
Holzhey DM, et al. Transapical versus conventional aortic valve replacement: A propensity-matched comparison. Heart Surg Forum 2012; 15:E4E8.
Barbanti M, et al. Acute kidney injury with the RenalGuard system in patients undergoing transcatheter aortic valve replacement: The PROTECT-TAVI Trial (PROphylactic effecT of furosEmide-induCed diuresis with matched isotonic intravenous hydraTion in Transcatheter Aortic Valve Implantation). JACC Cardiovasc Interv 2014; 7:1146–1155.
Makki N, Lilly SM. Advanced chronic kidney disease: Relationship to outcomes post-TAVR, a meta-analysis. Clin Cardiol 2018; 41:1091–1096.
Mohananey D, et al. Comparative outcomes of patients with advanced renal dysfunction undergoing transcatheter aortic valve replacement in the United States from 2011 to 2014. Circ Cardiovasc Interv 2017; 10(10). pii: e005477.
Gupta T, et al. Association of chronic kidney disease with in-hospital outcomes of transcatheter aortic valve replacement. JACC Cardiovasc Interv 2017; 10:2050–2060.
Voigtländer L, et al. pubmed Impact of kidney function on mortality after transcatheter valve implantation in patients with severe aortic valvular stenosis. Int J Cardiol 2015; 178:275–281.
Patel K, et al. Characteristics and outcomes of patients with aortic stenosis and chronic kidney disease. J Am Heart Assoc 2019; 8:e009980.
Kumar N, et al. Comparison of outcomes of transcatheter versus surgical aortic valve replacement in patients with chronic kidney disease. Am J Cardiol 2018; 121:343–348.
Kobrin DM, et al. Transcatheter and surgical aortic valve replacement in dialysis patients: a propensity-matched comparison. Ann Thorac Surg 2015; 100:1230–1236.
Alkhalil A, et al. In-hospital outcomes of transcatheter versus surgical aortic valve replacement in end stage renal disease. Catheter Cardiovasc Interv 2018; 92:757–765.
Kawase Y, et al. Severe aortic stenosis in dialysis patients. J Am Heart Assoc 2017; 6(7). pii: e004961.